International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas.
The international consensus guidelines for management of intraductal papillary mucinous neoplasm and mucinous cystic neoplasm of the pancreas established in 2006 have increased awareness and improved the management of these entities. During the subsequent 5 years, a considerable amount of information has been added to the literature. Based on a consensus symposium held during the 14th meeting of the International Association of Pancreatology in Fukuoka, Japan, in 2010, the working group has generated new guidelines. Since the levels of evidence for all items addressed in these guidelines are low, being 4 or 5, we still have to designate them "consensus", rather than "evidence-based", guidelines. To simplify the entire guidelines, we have adopted a statement format that differs from the 2006 guidelines, although the headings are similar to the previous guidelines, i.e., classification, investigation, indications for and methods of resection and other treatments, histological aspects, and methods of follow-up. The present guidelines include recent information and recommendations based on our current understanding, and highlight issues that remain controversial and areas where further research is required.
Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan. masaotan@med.kyushu-u.ac.jp
Masao
M
Tanaka
Carlos
C
Fernández-del Castillo
Volkan
V
Adsay
Suresh
S
Chari
Massimo
M
Falconi
Jin-Young
JY
Jang
Wataru
W
Kimura
Philippe
P
Levy
Martha Bishop
MB
Pitman
C Max
CM
Schmidt
Michio
M
Shimizu
Christopher L
CL
Wolfgang
Koji
K
Yamaguchi
Kenji
K
Yamao
D021441:Carcinoma, Pancreatic Ductal / Q000473:pathology / Q000628:therapy*; D006801:Humans; D018297:Neoplasms, Cystic, Mucinous, and Serous / Q000628:therapy*; D010179:Pancreas / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000628:therapy*; D018300:Papilloma, Intraductal / Q000628:therapy*